Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ISTH 2023 | Resolution of hemolysis in a patient with PNH treated with pegcetacoplan

Pranavi Sanka • 26 Jun 2023
ISTH 2023
Non-Malignant Paroxysmal Nocturnal Hemoglobinuria Rare Diseases Pegcetacoplan

In this video, Pranavi Sanka, MD, The Warren Alpert Medical School of Brown University, Providence, RI, discusses the promising outcomes observed in a patient with paroxysmal nocturnal hemoglobinuria (PNH) treated with pegcetacoplan. This interview took place at the 31st Congress of the International Society on Thrombosis and Haemostasis (ISTH), held in Montréal, Canada.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Pranavi Sanka

1:14
The value of pegcetacoplan in the PNH treatment landscape
Pranavi Sanka • 26 Jun 2023

Related Videos

2:01
The MDT in the new era of gene therapy for hemoglobinopathies
Mattia Algeri • 15 Apr 2024
2:38
Treosulfan vs busulfan conditioning in pediatric patients with non-malignant diseases
Rita Beier • 15 Apr 2024
3:18
Immune-mediated bone marrow failure diseases & their pathophysiology: aplastic anemia, LR-MDS & PNH
Carlo Dufour • 15 Apr 2024
1:11
Personalized risk assessment for transplantation in primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals